HUQ, Shihan Mahmud Redwanul et al.
Survival Benefit of High Dose Versus Usual Dose of Baricitinib in Hospitalized Patients with COVID-19: A Systematic Review.
Medical Research Archives, [S.l.], v. 10, n. 9, sep. 2022.
ISSN 2375-1924.
Available at: <https://esmed.org/MRA/mra/article/view/3076>. Date accessed: 06 nov. 2024.
doi: https://doi.org/10.18103/mra.v10i9.3076.